Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Corporation (ADPT $10.53)
- $10.53 Cap: $1.64B
- View ADPT Profile
- View Questions on ADPT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adaptive Biotechnologies Corporation (ADPT $10.53)
- $10.53 Cap: $1.64B
- View ADPT Profile
- View Questions on ADPT

Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?

Read Answer Asked by Pierre on June 15, 2023

Adaptive Biotechnologies Corporation (ADPT $10.53)
- $10.53 Cap: $1.64B
- View ADPT Profile
- View Questions on ADPT

Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?

Much appreciated,

Read Answer Asked by Jo on March 22, 2021

Amgen Inc. (AMGN $305.69)
- $305.69 P/E (TTM): 26.97X Cap: $159.09B
- View AMGN Profile
- View Questions on AMGN
Johnson & Johnson (JNJ $167.93)
- $167.93 P/E (TTM): 18.28X Cap: $395.46B
- View JNJ Profile
- View Questions on JNJ
Inovio Pharmaceuticals Inc. (INO $1.45)
- $1.45 Cap: $52M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $7.22)
- $7.22 P/E (TTM): 2.61X Cap: $1.13B
- View NVAX Profile
- View Questions on NVAX
Repligen Corporation (RGEN $114.12)
- $114.12 Cap: $6.53B
- View RGEN Profile
- View Questions on RGEN
Moderna Inc. (MRNA $32.73)
- $32.73 Cap: $12.08B
- View MRNA Profile
- View Questions on MRNA
Adaptive Biotechnologies Corporation (ADPT $10.53)
- $10.53 Cap: $1.64B
- View ADPT Profile
- View Questions on ADPT
Sorrento Therapeutics Inc. (SRNE)
- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Read Answer Asked by Antoine on June 30, 2020